Erectile dysfunction frequently coexists with coronary artery disease, affecting 50-70% of men with CAD, and can precede symptomatic CAD by 3-5 years.
What is the link between erectile dysfunction and coronary artery disease, and how should it be managed?
Erectile dysfunction frequently precedes symptomatic coronary artery disease by 3-5 years and serves as a marker for silent CAD, though treatment for ED remains safe in cardiac patients when properly evaluated.
INTRODUCTION: Erectile dysfunction (ED) is common and considered to be predominantly of vascular origin. AIM: To evaluate the link between ED and coronary artery disease (CAD) and provide a consensus report regarding evaluation and management. METHODS: A committee of eight experts from six countries was convened to review the worldwide literature concerning ED and CAD and provide a guideline for management. MAIN OUTCOME MEASURE: Expert opinion was based on grading the evidence-based medical literature, widespread internal committee discussion, public presentation, and debate. RESULTS: ED and CAD frequently coexist. Between 50-70% of men with CAD have ED. ED can arise before CAD is symptomatic with a time window of 3-5 years. ED and CAD share the same risk factors, and endothelial dysfunction is the common denominator. Treating ED in cardiac patients is safe, provided that their risks are properly evaluated. CONCLUSION: ED is a marker for silent CAD that needs to be excluded. Men with CAD frequently have ED that can be treated safely following guidelines.
Jackson et al. (Thu,) conducted a review in Erectile dysfunction and coronary artery disease. Erectile dysfunction was evaluated on Link between ED and CAD and management guidelines. Erectile dysfunction frequently coexists with coronary artery disease, affecting 50-70% of men with CAD, and can precede symptomatic CAD by 3-5 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: